Taming the lion: the challenge of immunity in regenerative medicine.

about

F4/80+ Host Macrophages Are a Barrier to Murine Embryonic Stem Cell-Derived Hematopoietic Progenitor Engraftment In Vivo.cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.iPS Cells-The Triumphs and Tribulations.

P2860

Q30828462-965E24A6-6477-43B1-8277-32C44C9A1B0C Q34045021-764D8EED-9A1F-4F48-A8CD-6A4DFE6D7C76 Q55398510-CD440F41-E13A-490F-890B-E754C4519C02

P2860

Taming the lion: the challenge of immunity in regenerative medicine.

Item

http://www.wikidata.org/entity/Q48039450

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Taming the lion: the challenge of immunity in regenerative medicine.

@en

Taming the lion: the challenge of immunity in regenerative medicine.

@nl

type

Item

label

Taming the lion: the challenge of immunity in regenerative medicine.

@en

Taming the lion: the challenge of immunity in regenerative medicine.

@nl

prefLabel

Taming the lion: the challenge of immunity in regenerative medicine.

@en

Taming the lion: the challenge of immunity in regenerative medicine.

@nl

P1476

Taming the lion: the challenge of immunity in regenerative medicine.

@en

P2093

Paul J Fairchild

http://www.w3.org/2001/XMLSchema#string

P2860

Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo?

Neonatal desensitization for the study of regenerative medicine.

Organizational profile: UK regenerative medicine platform immunomodulation hub.

Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy.

Avoiding immunological rejection in regenerative medicine.

Construction of a functional thymic microenvironment from pluripotent stem cells for the induction of central tolerance.

The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs.

The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.

The issue of immunology in stem cell therapies: a pharmaceutical perspective.

The UKRMP Immunomodulation hub.

P304

227-229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/RME.15.15

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275663418

http://www.w3.org/2001/XMLSchema#string

P698

25933229

http://www.w3.org/2001/XMLSchema#string

Taming the lion: the challenge of immunity in regenerative medicine.

about

P2860

P2860

Taming the lion: the challenge of immunity in regenerative medicine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698